VAV1 and breast carcinoma: LYN activity has been reported to promote the epithelial-mesenchymal transition through Vav-Rac1-PAK1-mediated control of SNAI protein localisation and stability in multiple cancer types, including breast cancer (Thaper et al., 2017).